DWT
EW icon

Dorsey & Whitney Trust’s Edwards Lifesciences EW Stock Holding History

Dorsey & Whitney Trust’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$452K Buy
4,999
+180
+4% +$15.1K 0.02% 471
2026
Q1 		$386K Buy
4,819
+22
+0.5% +$1.81K 0.02% 496
2025
Q4 		$409K Buy
4,797
+272
+6% +$22.3K 0.02% 478
2025
Q3 		$352K Sell
4,525
-153
-3% -$12K 0.02% 501
2025
Q2 		$366K Sell
4,678
-365
-7% -$27.2K 0.02% 494
2025
Q1 		$366K Sell
5,043
-50
-1% -$3.58K 0.02% 469
2024
Q4 		$377K Sell
5,093
-865
-15% -$60.5K 0.02% 455
2024
Q3 		$393K Buy
5,958
+615
+12% +$44.7K 0.02% 444
2024
Q2 		$494K Sell
5,343
-1,554
-23% -$138K 0.03% 358
2024
Q1 		$659K Sell
6,897
-195
-3% -$16.4K 0.05% 291
2023
Q4 		$541K Buy
7,092
+246
+4% +$17.1K 0.04% 329
2023
Q3 		$474K Sell
6,846
-1,556
-19% -$125K 0.04% 324
2023
Q2 		$793K Buy
8,402
+1,571
+23% +$137K 0.07% 241
2023
Q1 		$565K Buy
6,831
+2,132
+45% +$168K 0.05% 289
2022
Q4 		$351K Sell
4,699
-284
-6% -$21.9K 0.03% 373
2022
Q3 		$410K Buy
4,983
+302
+6% +$29.1K 0.04% 322
2022
Q2 		$445K Sell
4,681
-27
-0.6% -$2.79K 0.05% 307
2022
Q1 		$555K Buy
4,708
+121
+3% +$13.6K 0.05% 289
2021
Q4 		$595K Buy
4,587
+434
+10% +$50.6K 0.05% 270
2021
Q3 		$470K Buy
4,153
+116
+3% +$13.2K 0.04% 300
2021
Q2 		$417K Hold
4,037
– – 0.04% 318
2021
Q1 		$338K Buy
4,037
+448
+12% +$37.9K 0.03% 360
2020
Q4 		$328K Sell
3,589
-10
-0.3% -$829 0.04% 321
2020
Q3 		$288K Buy
3,599
+22
+0.6% +$1.72K 0.04% 311
2020
Q2 		$247K Buy
3,577
+355
+11% +$25.2K 0.03% 348
2020
Q1 		$203K Buy
3,222
+12
+0.4% +$865 0.03% 349
2019
Q4 		$250K Buy
3,210
+63
+2% +$4.92K 0.03% 362
2019
Q3 		$230K Buy
+3,147
New +$221K 0.03% 359

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Dorsey & Whitney Trust's EW Position: Q2 2026 in Review

Dorsey & Whitney Trust increased its Edwards Lifesciences (EW) stake by 3.7% in Q2 2026, buying an estimated $15.1K and bringing the position to 4,999 shares worth $452K. The position accounts for 0.02% of the portfolio, ranked #471.

Dorsey & Whitney Trust first reported a position in EW in Q3 2019 and has held it in 28 quarters since. The position peaked at $793K in Q2 2023. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Dorsey & Whitney Trust held 4,999 shares of Edwards Lifesciences worth $452K as of Q2 2026.
  • Dorsey & Whitney Trust bought 180 Edwards Lifesciences shares in Q2 2026, an estimated $15.1K.
  • Edwards Lifesciences made up 0.02% of Dorsey & Whitney Trust's portfolio in Q2 2026, its #471 holding.
  • Dorsey & Whitney Trust first reported a position in Edwards Lifesciences in Q3 2019 and has held it in 28 quarters since.
  • Dorsey & Whitney Trust's Edwards Lifesciences position peaked at $793K in Q2 2023.
  • 1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Dorsey & Whitney Trust's 13F filing for Q2 2026, filed 14 Aug 2026.